/PLSE

PLSE Stock - Pulse Biosciences, Inc.

Q: What is the analyst price target for PLSE?

Analyst price target information is not currently available for PLSE.

Q: What is PLSE's market cap?

Market capitalization information is not currently available for PLSE.

Healthcare|Medical - Instruments & Supplies|NASDAQ

$14.15-2.88%

$0.42 (-2.88%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $15.57

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PLSE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.69

52W High$25.00

52W Low$12.56

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	$700,000	$1.42M	N/A
Gross Profit	N/A	$-1,207,000	$-11,244,000	$-550,000	$-1,095,000
Gross Margin	N/A	N/A	-1606.3%	-38.8%	N/A
Operating Income	$-56,257,000	$-43,574,000	$-58,057,000	$-63,014,000	$-49,965,000
Net Income	$-53,585,000	$-42,210,000	$-58,505,000	$-63,660,000	$-49,737,000
Net Margin	N/A	N/A	-8357.9%	-4489.4%	N/A
EPS	$-0.92	$-0.88	$-1.72	$-2.28	$-2.14

Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Visit Website

Earnings History & Surprises

PLSE

Beat Rate

78%

Last 18 quarters

Avg Surprise

+17.6%

EPS vs Estimate

Beats / Misses

14/3

1 met exactly

Latest EPS

$-0.29

Q4 2025

EPS Surprise History

Q1 24

+37.5%

$-0.15vs$-0.24

Q2 24

+41.7%

$-0.14vs$-0.24

Q3 24

+17.1%

$-0.20vs$-0.24

Q4 24

+33.3%

$-0.16vs$-0.24

Q1 25

+29.2%

$-0.17vs$-0.24

Q2 25

No data

Q3 25

-7.7%

$-0.28vs$-0.26

Q4 25

+6.5%

$-0.29vs$-0.31

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 26, 2026	$-0.32	—	—	—
Q4 2025	Nov 5, 2025	$-0.31	$-0.29	+6.5%	✓ BEAT
Q3 2025	Aug 12, 2025	$-0.26	$-0.28	-7.7%	✗ MISS
Q2 2025	May 8, 2025	—	$-0.17	—	—
Q1 2025	Mar 27, 2025	$-0.24	$-0.17	+29.2%	✓ BEAT
Q4 2024	Oct 30, 2024	$-0.24	$-0.16	+33.3%	✓ BEAT
Q3 2024	Aug 19, 2024	$-0.24	$-0.20	+17.1%	✓ BEAT
Q2 2024	May 7, 2024	$-0.24	$-0.14	+41.7%	✓ BEAT
Q1 2024	Mar 28, 2024	$-0.24	$-0.15	+37.5%	✓ BEAT
Q4 2023	Nov 13, 2023	$-0.24	$-0.15	+37.5%	✓ BEAT
Q3 2023	Aug 10, 2023	$-0.22	$-0.19	+13.6%	✓ BEAT
Q2 2023	May 11, 2023	$-0.22	$-0.23	-4.5%	✗ MISS
Q1 2023	Mar 30, 2023	$-0.24	$-0.22	+8.3%	✓ BEAT
Q4 2022	Nov 10, 2022	$-0.45	$-0.46	-2.2%	✗ MISS
Q3 2022	Aug 10, 2022	$-0.37	$-0.37	0.0%	= MET
Q2 2022	May 11, 2022	$-0.51	$-0.48	+5.9%	✓ BEAT
Q1 2022	Mar 31, 2022	$-0.50	$-0.39	+22.0%	✓ BEAT
Q4 2021	Nov 15, 2021	$-0.54	$-0.42	+22.2%	✓ BEAT
Q3 2021	Aug 9, 2021	$-0.79	$-0.48	+39.2%	✓ BEAT
Q2 2021	May 10, 2021	$-0.52	$-0.43	+17.3%	✓ BEAT

Frequently Asked Questions about PLSE

What is PLSE's current stock price?

Pulse Biosciences, Inc. (PLSE) is currently trading at $14.15 per share. The stock has moved -2.88% today.

What is the analyst price target for PLSE?

No analyst price targets are currently available for this stock.

What sector is Pulse Biosciences, Inc. in?

Pulse Biosciences, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.

What is PLSE's market cap?

Pulse Biosciences, Inc. has a market capitalization of $0.96 billion, making it a small-cap company.

Does PLSE pay dividends?

No, Pulse Biosciences, Inc. does not currently pay a dividend to shareholders.